Discover why TCAF’s high-growth portfolio including MSFT, NVDA & AMZN may not justify its overvaluation. Explore valuation concerns & alternatives.
TCAF Struggles To Outpace S&P 500, Cheaper Alternatives Exist, Sell
view original post
Discover why TCAF’s high-growth portfolio including MSFT, NVDA & AMZN may not justify its overvaluation. Explore valuation concerns & alternatives.